128 related articles for article (PubMed ID: 31393173)
41. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
Newell ML; Huang S; Fiore S; Thorne C; Mandelbrot L; Sullivan JL; Maupin R; Delke I; Watts DH; Gelber RD; Cunningham CK;
BMC Infect Dis; 2007 Jun; 7():60. PubMed ID: 17584491
[TBL] [Abstract][Full Text] [Related]
42. Trends in antiretroviral use in pregnancy in the UK and Ireland, 2008-2018.
Rasi V; Peters H; Sconza R; Francis K; Bukasa L; Thorne C; Cortina-Borja M
HIV Med; 2022 Apr; 23(4):397-405. PubMed ID: 35178841
[TBL] [Abstract][Full Text] [Related]
43. Unintended pregnancy and viral suppression in pregnant women living with HIV.
Dude AM; Miller ES; Garcia PM; Yee LM
Am J Obstet Gynecol MFM; 2021 Mar; 3(2):100300. PubMed ID: 33359637
[TBL] [Abstract][Full Text] [Related]
44. Surgical implications of HIV infection.
Millar AJW; Cox SG
Pediatr Surg Int; 2022 Dec; 39(1):39. PubMed ID: 36482099
[TBL] [Abstract][Full Text] [Related]
45. Racial Disparities in HIV Care Extend to Common Comorbidities: Implications for Implementation of Interventions to Reduce Disparities in HIV Care.
Richardson KK; Bokhour B; McInnes DK; Yakovchenko V; Okwara L; Midboe AM; Skolnik A; Vaughan-Sarrazin M; Asch SM; Gifford AL; Ohl ME
J Natl Med Assoc; 2016; 108(4):201-210.e3. PubMed ID: 27979005
[TBL] [Abstract][Full Text] [Related]
46. Trends in provider-advised HIV antiretroviral therapy deferral in the United States, 2009-2014.
Beer L; Weiser J; Luke Shouse R
AIDS Care; 2019 Jul; 31(7):821-826. PubMed ID: 30466314
[TBL] [Abstract][Full Text] [Related]
47. Effect of antiretroviral therapy on hemostasis in Brazilian pregnant women with HIV infection.
de Andrade CM; Duarte G; Quintana SM; Montes MB; Toloi MR
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):769-74. PubMed ID: 17982318
[TBL] [Abstract][Full Text] [Related]
48. The Lived Experience of Antiretroviral Therapy for Pregnant Women: Antiretroviral Therapy Adherence as a Balancing Act.
Shore JE; Paun O; Vonderheid SC
J Assoc Nurses AIDS Care; 2020; 31(4):448-456. PubMed ID: 31094866
[TBL] [Abstract][Full Text] [Related]
49. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ
Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677
[TBL] [Abstract][Full Text] [Related]
50. HIV testing among pregnant women with prenatal care in the United States: An analysis of the 2011-2017 National Survey of Family Growth.
Olakunde BO; Pharr JR; Adeyinka DA
Int J STD AIDS; 2020 Jun; 31(7):680-688. PubMed ID: 32538331
[TBL] [Abstract][Full Text] [Related]
51. Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States.
Venkatesh KK; Morrison L; Tuomala RE; Stek A; Read JS; Shapiro DE; Livingston EG
Clin Infect Dis; 2021 Sep; 73(6):969-978. PubMed ID: 33768226
[TBL] [Abstract][Full Text] [Related]
52. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
[No Abstract] [Full Text] [Related]
53. Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance.
Gingelmaier A; Eberle J; Kost BP; Bogner JR; Hofmann J; Weissenbacher T; Kästner R; Friese K; Weizsaecker K
Clin Infect Dis; 2010 Mar; 50(6):890-4. PubMed ID: 20166821
[TBL] [Abstract][Full Text] [Related]
54. Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens.
Jamisse L; Balkus J; Hitti J; Gloyd S; Manuel R; Osman N; Djedje M; Farquhar C
J Acquir Immune Defic Syndr; 2007 Apr; 44(4):371-6. PubMed ID: 17259905
[TBL] [Abstract][Full Text] [Related]
55. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Curry SJ; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Jun; 321(23):2326-2336. PubMed ID: 31184701
[TBL] [Abstract][Full Text] [Related]
56. Pregnancy outcomes among HIV-infected women undergoing antiretroviral therapy.
Areechokchai D; Bowonwatanuwong C; Phonrat B; Pitisuttithum P; Maek-A-Nantawat W
Open AIDS J; 2009 Mar; 3():8-13. PubMed ID: 19543534
[TBL] [Abstract][Full Text] [Related]
57. Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.
Rough K; Tassiopoulos K; Kacanek D; Griner R; Yogev R; Rich KC; Seage GR;
AIDS; 2015 Jan; 29(1):117-23. PubMed ID: 25562496
[TBL] [Abstract][Full Text] [Related]
58. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.
Turner BJ; Newschaffer CJ; Zhang D; Cosler L; Hauck WW
Med Care; 2000 Sep; 38(9):911-25. PubMed ID: 10982113
[TBL] [Abstract][Full Text] [Related]
59. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis.
Laine C; Newschaffer CJ; Zhang D; Cosler L; Hauck WW; Turner BJ
Obstet Gynecol; 2000 Feb; 95(2):167-73. PubMed ID: 10674574
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
